Sign in
Taking peopleNo phase

Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia

Key facts

Who runs it
Centre Hospitalier le Mans
Where
France16 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
2,400 people, planned
Started
7 Nov 2024
Expected to end
7 Apr 2027
Type of study
Interventional, 2 groups
Treatments tested
  • nasogastric tube and orogastric tube
  • orogastric tube and nasogastric tube
Record updated
10 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • patient in intensive care, intubated, ventilated
  • Adult
  • Requiring a gastric tube
  • With an expected duration of mechanical ventilation of more than 48 hours
  • Affiliated to social security
  • Patient or relative consent or, failing that, emergency inclusion of the patient

Who cannot take part

  • Pregnant, breast-feeding or parturient women
  • Patients under legal protection: curatorship and guardianship
  • Contraindication to placing a gastric tube through the nose or mouth
  • Patients who already have a gastric tube when they enter the service
  • Patient intubated for more than 24 hours
  • Patient intubated via the nasotracheal route

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth.

Read full original descriptionShow less

In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital.

Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route.

Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.

The 2 groups in the trial

  • NasogastricTreatment being tested

    nasogastric tube in period 1 and orogastric tube in period 2

    Treatment: nasogastric tube and orogastric tube

  • OrogastricTreatment being tested

    orogastric tube in period 1 and nasogastric tube in period 2

    Treatment: orogastric tube and nasogastric tube

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia and Other Complications in the Intensive Care Unit
Publications
Record updated
10 September 2026